Recent news on Norelgestromin

Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI ...  -  May 9, 2007
PR Newswire (press release),...(norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride),

Ortho Evra Contraceptive Patch Information  -  Apr 26, 2007
InjuryBoard.com,The weekly prescription patch releases norelgestromin (a progestin hormone), and ethinyl estradiol (an estrogen hormone), through the skin into the blood

Report Shows Popular Birth Control Pill, ORTHO TRI-CYCLEN(R) LO ...  -  Apr 12, 2007
Drug Newswire (press release),...is committed to meeting the needs of providers and patients with products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system),

Results of Two Epidemiological Studies Provide Important New ...  -  Apr 12, 2007
Drug Newswire (press release),16 /PRNewswire/ -- Ortho Women's Health & Urology, the maker of the ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system) birth control patch,

Parker Waichman Alonso Mark LLP Believes New Study Confirms Ortho ...  -  Feb 23, 2007
WebWire (press release),The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream every 24 hours. It is replaced once a week

Contraceptive Patch More Likely Than Pill to Cause Venous ...  -  Feb 20, 2007
Medscape (subscription)The study involved 49048 women who used the norelgestromin/ethinyl estradiol patch (Ortho Evra) and 202344 who used norgestimate-containing oral

Lawsuit Filed Against Johnson & Johnson in Los Angeles Over Ortho ...  -  Feb 15, 2007
Emediawire (press release),The patch also contains norelgestromin, which the complaint says the FDA has found to increase the risks of venous thromboembolism even further.

FDA Safety Changes: Ortho Evra, Avastin, Trizivir  -  Dec 13, 2006
Medscape (subscription)On September 20, the FDA approved safety labeling revisions for a norelgestromin/ethinyl estradiol transdermal system (Ortho Evra, made by Ortho-McNeil

Nurse Practitioners Of Women's Health Publishes Issue Highlighting ...  -  Dec 11, 2006
Medical News Today (press release),Inc., and makers of ORTHO TRI-CYCLEN® Lo (ethinyl estradiol/norgestimate) and ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system),

Nurse Practitioners of Women's Health Publishes Issue Highlighting ...  -  Dec 6, 2006
Drug Newswire (press release),Inc. and makers of Ortho Tri-Cyclen(R) Lo (norgestimate/ethinyl estradiol) and Ortho Evra(R) (norelgestromin/ethinyl estradiol transdermal system),

Source: Parker & Waichman Attorneys at Law  Nov 6, 2006
...abdomen. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... -PrimeZone (press release), Lawsuit against Makers of Birth-Control Patches  Nov 2, 2006
...in lungs and legs. Ortho Evra is a 3-layered, matrix-like patch containing ethinyl estradiol and norelgestromin. When attached to ... -Spotlighting News Parker & Waichman, LLP Contacted by Many Women who were Previously ...  24 Sep 2006
...abdomen. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... -WebWire

FDA- MedWatch - Ortho Evra (norelgestromin/ethinyl estradiol)  Sep 20, 2006
ROCKVILLE, Md., Sept. 20, 2006-Ortho-McNeil and FDA notified healthcare professionals and patients about revisions to the prescribing ... -PharmaLive.com

FDA Warns of Serious Blood Clot Risk in Women on Ortho Evra ...  Sep 21, 2006
...of two separate epidemiology studies that evaluated the risk of developing a serious blood clot in women using Ortho Evra (norelgestromin/ethinyl estradiol ... -DG News

Ortho Evra Patch Linked to Risk for Venous Thromboembolism  Sep 21, 2006
...a Johnson & Johnson company) have notified healthcare professionals regarding changes to the safety labeling for a weekly norelgestromin/ethinyl estradiol ... -Medscape (subscription)

500 Ortho-Evra Birth Control Patch Victims Sue Johnson & Johnson  Sep 20, 2006
VTE) associated with this new transdermal combination hormonal contraceptive containing the new molecular entity progestin norelgestromin (17d-norgestimate ... -Best Syndication

Health Canada Reviews Birth Control Patch Risks  Sep 21, 2006
The Ortho-Evra EVRA (norelgestromin/ethinyl estradiol transdermal system) patch may carry an increased risk of blood clots, according to a study. ... -Toronto Daily News

Health Canada Endorsed Important Safety Information on Evra ...  -  Nov 23, 2006
DG NewsThe Evra* transdermal system marketed in Canada contains 6.0 mg norelgestromin (NGMN) and 0.60 mg ethinyl estradiol (EE) and is approved for use in

Nurse Practitioners Of Women's Health Publishes Issue Highlighting ...  -  Dec 11, 2006
Medical News Today (press release),Inc., and makers of ORTHO TRI-CYCLEN® Lo (ethinyl estradiol/norgestimate) and ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system),

Nurse Practitioners of Women's Health Publishes Issue Highlighting ...  -  Dec 6, 2006
Drug Newswire (press release),Inc. and makers of Ortho Tri-Cyclen(R) Lo (norgestimate/ethinyl estradiol) and Ortho Evra(R) (norelgestromin/ethinyl estradiol transdermal system),

Woman Injured by Ortho Evra Birth Control Patch Files Suit  Aug 24, 2006
...abdomen. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... -Newsinferno.com

Survey Sheds Light On Mistaken Identities Of Interstitial Cystitis ...  Aug 20, 2006
...to helping people live healthier lives and to meeting the needs of providers and patients with products such as ORTHO EVRA® (norelgestromin/ethinyl estradiol ... -Medical News Today

Ortho Celebrates 75 Years of Partnering With Women  Jul 25, 2006
...introduced a new delivery system to appeal to women seeking more convenience in their contraceptive choice - ORTHO EVRA(R) (norelgestromin/ethinyl estradiol ... -PR Newswire

Peterson & Associates, PC Continues Its Investigation of Ortho ...  Aug 7, 2006
...buttocks. It is intended to administer 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... -PrimeZone

Parker & Waichman, LLP Files Suit Against Ortho-McNeil ...  Jul 13, 2006
...abdomen. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... -PrimeZone



Report Shows Popular Birth Control Pill, Ortho Tri-Cyclen(R) LO ...  May 11, 2006
...of healthcare professionals, is committed to meeting the needs of providers and patients with products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol ... - Medical News Today

Ortho Evra Birth Control Patch Allegedly Linked to Heart Attack ...  Apr 17, 2006
...birth control patch contains more hormones than the traditional birth control pill and these hormones, progestin, estrogen, and norelgestromin, are delivered ... - Emediawire





Ortho-McNeil Reportedly Trying to Settle Outstanding Claims ...  11 Apr 2006
...report published by the Associated Press on July 18, 2005 linked the birth control patch, which contains a combination of norelgestromin and ethinyl estradiol ... - Newsinferno.com

(PZ) Parker & Waichman, LLP Files Suit Against Ortho-McNeil ...  Mar 17, 2006
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - Houston Chronicle



Results of Two Epidemiological Studies Provide Important New ...  Feb 16, 2006
16 /PRNewswire/ -- Ortho Women's Health & Urology, the maker of the ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system) birth control patch ... - International News Service,

Evidence on Ortho Evra Patch Thrombosis Risk Is Contradictory  Feb 17, 2006
Interim results of an epidemiologic study indicated that women who use Ortho Evra (norelgestromin/ethinyl estradiol transdermal system) had about a two-fold ... - MedPage Today,

Blood clot warning to go on Ortho Evra birth control patch  Feb 19, 2006
Ortho Evra is a weekly prescription patch that releases ethinyl estradiol (an estrogen hormone) and norelgestromin (a progestin hormone) through the skin into ... - News-Medical.net,

Studies Of Birth-control Patch REvelaed Important New Clinical ...  Feb 18, 2006
Ortho Women's Health & Urology, the maker of the ORTHO EVRA (norelgestromin/ethinyl estradiol transdermal system) birth control patch, has received the first ... - Playfuls.com,

PRN/BW Texas  Jan 27, 2006
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - Houston Chronicle

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional